FATE 8-K 2026-09-28

FATE THERAPEUTICS INC (FATE) 8-K dated 2026-09-28 — accession 0001193125-26-403429. This URL is the filing, not the FATE hub.

FATE THERAPEUTICS INC (FATE) is a biotechnology company listed on US.

FATE THERAPEUTICS INC filed a 8-K on 2026-09-28. Accession 0001193125-26-403429.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported FATE revenue for 2025-12-31 was $6.6M. Net income was -$136.3M. Revenue was down 51.2% from 2024-12-31 to 2025-12-31. FATE currently screens at market cap $331.0M.

Not investment advice. The FATE SEC hub lists recent forms. The stock page is the research view.